Literature DB >> 11881745

Cholesterol, A beta and Alzheimer's disease.

T Hartmann1.   

Abstract

Statins have been used for many years for the treatment of hypercholesterolemia. They lower low-density lipoprotein (LDL) cholesterol, increase high-density lipoprotein (HDL) levels and are considered to be very safe. Recently, a set of potential new applications was identified for statins. In the future, these drugs could be used to treat Alzheimer's disease (AD). Past studies have suggested a link between AD and lipids and a series of reports has recently been published that significantly tightens this link and also provides some explanations at the cellular level. This review focuses on these recent developments and perspectives that appear to link cholesterol, beta-amyloid and AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11881745     DOI: 10.1016/s0166-2236(00)01990-1

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  35 in total

Review 1.  Malformation syndromes due to inborn errors of cholesterol synthesis.

Authors:  Forbes D Porter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Authors:  Anne M Fagan; Erin Christopher; Jennie W Taylor; Maia Parsadanian; Michael Spinner; Melanie Watson; John D Fryer; Suzanne Wahrle; Kelly R Bales; Steven M Paul; David M Holtzman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

3.  Cellular cholesterol controls TRPC3 function: evidence from a novel dominant-negative knockdown strategy.

Authors:  Annarita Graziani; Christian Rosker; Sepp D Kohlwein; Michael X Zhu; Christoph Romanin; Wolfgang Sattler; Klaus Groschner; Michael Poteser
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

4.  Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.

Authors:  Hagit Katzov; Anna M Bennet; Kina Höglund; Björn Wiman; Dieter Lütjohann; Anthony J Brookes; Niels Andreasen; Kaj Blennow; Ulf De Faire; Jonathan A Prince
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

Review 5.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

6.  Population-based analysis of cholesteryl ester transfer protein identifies association between I405V and cognitive decline: the Cache County Study.

Authors:  Caitlin Lythgoe; Ammon Perkes; Michael Peterson; Cameron Schmutz; Maegan Leary; Mark T W Ebbert; Perry G Ridge; Maria C Norton; JoAnn T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2014-08-27       Impact factor: 4.673

Review 7.  Beta-amyloid and cholinergic neurons.

Authors:  Vladimír Dolezal; Jana Kasparová
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 8.  Sterols and sphingolipids: dynamic duo or partners in crime?

Authors:  Sonia Gulati; Ying Liu; Andrew B Munkacsi; Lisa Wilcox; Stephen L Sturley
Journal:  Prog Lipid Res       Date:  2010-04-01       Impact factor: 16.195

9.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

Authors:  Lawrence Rajendran; Masanori Honsho; Tobias R Zahn; Patrick Keller; Kathrin D Geiger; Paul Verkade; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-12       Impact factor: 11.205

Review 10.  Role of acyl-coenzyme a: cholesterol acyltransferase activity in the processing of the amyloid precursor protein.

Authors:  Luigi Puglielli; Blake C Ellis; Laura A MacKenzie Ingano; Dora M Kovacs
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.